HLA DQ Antikörper (PE,Cy5)
Kurzübersicht für HLA DQ Antikörper (PE,Cy5) (ABIN7670250)
Target
Reaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Verwendungszweck
- PE/Cyanine5 Anti-Human HLA-DQ Antibody[1a3]
-
Immunogen
- E-AB-F09802G
-
Isotyp
- IgG2a, kappa
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 5 μL/tests
-
Buffer
- Phosphate buffered solution, pH 7.2, containing 0.09 % stabilizer and 1 % protein protectant.
-
Handhabung
- Please protected from prolonged exposure to light and do not freeze.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- This product can be stored at 2-8°C for 12 months.
-
Haltbarkeit
- 12 months
-
-
- HLA DQ (HLA-DQ) (MHC Class II HLA-DQ (HLA-DQ))
-
Andere Bezeichnung
- HLA-DQ
-
Hintergrund
- Muc-18,MCAM,Mel-CAM,S-endo,HLA-DQ is also known as MHC class II DQ monomorphic antigen. The major histocompatibility complex is composed of two heterodimeric glycoproteins (α and β chains) with apparent molecular weights of 27 and 32 kD. In contrast to other MHC class II molecules, both polypeptide chains of HLA-DQ are polymorphic, with the α chain showing an extremely high degree of polymorphism. HLA-DQ is expressed on B cells in the peripheral blood, and weakly expressed on activated T cells and some monocytes. HLA-DQ is absent on hematopoietic progenitors, resting T cells, erythrocytes, and platelets. HLA-DQ is expressed after HLA-DR and HLA-DP in hematopoietic development. HLA-DQ presents peptide fragments mainly from degraded intravesicular and extracellular proteins to CD4+ T lymphocytes. Specific alleles of HLA-DQ have been linked to the pathogenesis of several autoimmune diseases (including diabetes), both as a susceptibility and resistance factor depending on the particular polymorphism.
-
UniProt
- P43121
Target
-